EMR vs GLUE · P/E 34, rev $4.86B vs rev $123.7M
Emerson Electric Company (EMR) versus Monte Rosa Therapeutics Inc (GLUE) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. GLUE currently screens at market cap $1.56B.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. GLUE currently screens at market cap $1.56B.
Not investment advice. Open the EMR and GLUE stock pages for the full models.
Not investment advice.